ArticleSocial psychiatry and psychiatric epidemiology2026
Psychotropic medication trajectories around parental bereavement and their association with suicide mortality among adolescents and young adults, a Swedish nationwide cohort study.
Article in Social psychiatry and psychiatric epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeParental death during adolescence or young adulthood (AYA) is a significant life event with profound psychological consequences and may initiate or escalate psychotropic medication use. This study identified distinct psychotropic medication use trajectories around parental bereavement, their associations with suicide mortality, and factors characterizing trajectory membership.
methodsUsing Swedish national registers, we identified individuals born in Sweden between 1977 and 2010 who experienced parental death for the first time between the ages of 10 and 29 years (n = 141,006). Psychotropic medication use was modeled from two years before to four years after bereavement using zero-inflated Poisson group-based trajectory modeling. Associations with suicide mortality were examined using Cox regression, and factors characterizing trajectory membership were assessed using multinomial logistic regression.
resultsFour trajectories emerged: low/no use (80.6%), post-loss increasing (8.4%), post-loss declining (5.7%), and persistent high use (5.3%). Compared with the low/no use group, all other trajectories, including the post-loss declining group, were associated with elevated suicide mortality (HRs 2.81-3.13; 95% CIs: 1.65─5.30). Associations were stronger following natural parental death (HRs 3.26-4.07; 95% CIs: 1.77─7.57) and among those predominantly using sedatives (HRs 5.20-7.70; 95% CIs: 1.78─21.7). Pre-loss psychiatric history, female sex, lower socioeconomic background, and unnatural parental death were the strongest factors associated with membership in psychotropic medication use trajectory groups.
conclusionPsychotropic medication trajectories around parental bereavement may serve as markers of suicidal vulnerability among AYAs. The higher risk of suicide mortality in the post-loss declining group suggests that reductions in treatment intensity may not always reflect mental health recovery. Post-bereavement monitoring should integrate medication use patterns with clinical and sociodemographic indicators of vulnerability.
Indexed as
Identifiers
42853257What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.